RESUMEN
Optimization of individual immunosuppression, which reduces the risks of both graft loss and patients' death, is considered the best approach to improve long-term outcomes of renal transplantation. Torque Teno Virus (TTV) DNAemia has emerged as a potential biomarker reflecting the depth of therapeutic immunosuppression during the initial year post-transplantation. However, its efficacy in long-term monitoring remains uncertain. In a cohort study involving 34 stable kidney transplant recipients and 124 healthy volunteers, we established lower and upper TTV DNAemia thresholds (3.75-5.1 log10 cp/mL) correlating with T-cell activatability, antibody response against flu vaccine, and risk for subsequent serious infections or cancer over 50 months. Validation in an independent cohort of 92 recipients confirmed that maintaining TTV DNAemia within this range in >50% of follow-up time points was associated with reduced risks of complications due to inadequate immunosuppression, including de novo DSA, biopsy-proven antibody-mediated rejection, graft loss, infections, or cancer. Multivariate analysis highlighted "in-target" TTV DNAemia as the sole independent variable significantly linked to decreased risk for long-term complications due to inadequate immunosuppression (odds ratio [OR]: 0.27 [0.09-0.77]; p = 0.019). Our data suggest that the longitudinal monitoring of TTV DNAemia in kidney transplant recipients could help preventing the long-term complications due to inadequate immunosuppression.
Asunto(s)
Infecciones por Virus ADN , ADN Viral , Terapia de Inmunosupresión , Trasplante de Riñón , Torque teno virus , Receptores de Trasplantes , Humanos , Torque teno virus/genética , Trasplante de Riñón/efectos adversos , Masculino , Femenino , Persona de Mediana Edad , ADN Viral/sangre , Adulto , Infecciones por Virus ADN/virología , Infecciones por Virus ADN/sangre , Infecciones por Virus ADN/inmunología , Terapia de Inmunosupresión/efectos adversos , Estudios Longitudinales , Anciano , Rechazo de Injerto , Inmunosupresores/uso terapéutico , Inmunosupresores/efectos adversos , Estudios de Cohortes , ViremiaRESUMEN
Novel biomarkers reflecting the degree of immunosuppression in transplant patients are required to ensure eventual personalized equilibrium between rejection and infection risks. With the above aim, Torque Teno Virus (TTV) viremia was precisely examined in a large cohort of transplanted immunocompromised patients (192 hematological and 60 solid organ transplant recipients) being monitored for Cytomegalovirus reactivation. TTV load was measured in 2612 plasma samples from 448 patients. The results revealed a significant increase in TTV viral load approximately 14 days following CMV reactivation/infection in solid organ transplant (SOT) patients. No recognizable difference in TTV load was noted among hematological patients during the entire timeframe analyzed. Furthermore, a temporal gap of approximately 30 days was noted between the viral load peaks reached by the two viruses, with Cytomegalovirus (CMV) preceding TTV. It was not possible to establish a correlation between CMV reactivation/infection and TTV viremia in hematological patients. On the other hand, the SOT patient cohort allowed us to analyze viral kinetics and draw intriguing conclusions. Taken together, the data suggest, to our knowledge for the first time, that CMV infection itself could potentially cause an increase in TTV load in the peripheral blood of patients undergoing immunosuppressive therapy.
Asunto(s)
Infecciones por Citomegalovirus , Citomegalovirus , Infecciones por Virus ADN , Huésped Inmunocomprometido , Torque teno virus , Carga Viral , Viremia , Humanos , Citomegalovirus/inmunología , Citomegalovirus/fisiología , Infecciones por Citomegalovirus/virología , Infecciones por Citomegalovirus/inmunología , Infecciones por Citomegalovirus/sangre , Masculino , Infecciones por Virus ADN/virología , Infecciones por Virus ADN/sangre , Infecciones por Virus ADN/inmunología , Persona de Mediana Edad , Femenino , Adulto , Terapia de Inmunosupresión/efectos adversos , Activación Viral , Receptores de Trasplantes/estadística & datos numéricos , Anciano , Estudios de CohortesRESUMEN
Torque Teno Virus (TTV) is a ubiquitous component of the human virome, not associated with any disease. As its load increases when the immune system is compromised, such as in kidney transplant (KT) recipients, TTV load monitoring has been proposed as a method to assess immunosuppression. In this prospective study, TTV load was measured in plasma and urine samples from 42 KT recipients, immediately before KT and in the first 150 days after it. Data obtained suggest that TTV could be a relevant marker for evaluating immune status and could be used as a guide to predict the onset of infectious complications in the follow-up of KT recipients. Since we observed no differences considering distance from transplantation, while we found a changing trend in days before viral infections, we suggest to consider changes over time in the same subjects, irrespective of time distance from transplantation.
Asunto(s)
Biomarcadores , Trasplante de Riñón , Torque teno virus , Carga Viral , Trasplante de Riñón/efectos adversos , Humanos , Biomarcadores/orina , Biomarcadores/sangre , Masculino , Persona de Mediana Edad , Femenino , Adulto , Infecciones por Virus ADN/orina , Infecciones por Virus ADN/sangre , Infecciones por Virus ADN/virología , Estudios Prospectivos , Receptores de Trasplantes , AncianoRESUMEN
BACKGROUND: Torquetenovirus (TTV) viremia is emerging as a promising tool to assess functional immune competence, to predict posttransplant immune-related complications, and eventually to customize immunosuppression. METHODS: In this study, 327 blood samples were tested using two real-time PCR (rtPCR) assays both targeted to the untranslated region of the TTV genome. The first assay was an in-house rtPCR developed by our group, the second one was the recently marketed TTV R-GENE assay. RESULTS: In the validation study, the TTV R-GENE showed good performances in precision and reproducibility, and sensitivity as low as 12 TTV DNA copies/mL, like previously reported for the in-house rtPCR. The Bland-Altman analysis showed that the mean difference between the two methods was -0.3 log copies/mL. In the comparison study, 69% and 72% of samples were detected positive by rtPCR and TTV R-GENE, respectively (94% concordance, κ = 0.88). Performances did not differ between the two rtPCRs by type of TTV group examined. When a newly-developed in-house digital droplet PCR was applied for TTV quantification and used as an alternative method of comparison on 94 samples, the results strongly correlated with those obtained by the two rtPCR methods (99% concordance). CONCLUSION: In summary, all the molecular methods assayed are highly sensitive and accurate in quantitation of TTV DNA in blood samples.
Asunto(s)
Biomarcadores/sangre , Infecciones por Virus ADN/sangre , Reacción en Cadena en Tiempo Real de la Polimerasa/métodos , Torque teno virus/fisiología , Viremia/sangre , Estudios de Casos y Controles , Infecciones por Virus ADN/inmunología , ADN Viral/sangre , Humanos , Inmunocompetencia , Reproducibilidad de los Resultados , Viremia/inmunologíaRESUMEN
Monitoring of alphatorquevirus (torque teno virus [TTV]) DNA in plasma may prove to be useful to assess the net state of immune competence following allogeneic hematopoietic stem cell transplantation (allo-HSCT). There are scarce data published on the prevalence of beta (torque teno mini virus [TTMV]) and gammatorqueviruses (torque teno midi virus [TTMDV]) and, in particular, on the dynamics of anelloviruses in allo-HSCT patients. Twenty-five allo-HSCT recipients with available plasma specimens obtained before conditioning and after engraftment were included. Degenerated primers targeting a highly conserved genomic sequence across all anelloviruses were designed for genomic amplification and high-throughput sequencing. Co-detection of TTV, TTMV, and TTMDV both in pre-transplant and post-engraftment plasma specimens was documented in more than two-thirds of patients. The use of quantitative real-time polymerase chain reaction (PCR) assays targeting TTMV and TTMDV in addition to TTV may add value to TTV-specific PCR assays in the inference of the net state of immunosuppresion or immune competence in this clinical setting.
Asunto(s)
Anelloviridae/genética , Infecciones por Virus ADN/virología , Trasplante de Células Madre Hematopoyéticas , Adulto , Anciano , Anelloviridae/clasificación , Anelloviridae/aislamiento & purificación , Infecciones por Virus ADN/sangre , Infecciones por Virus ADN/inmunología , ADN Viral/sangre , ADN Viral/genética , Femenino , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Humanos , Masculino , Persona de Mediana Edad , Plasma/virología , Trasplante HomólogoRESUMEN
Exosomes are associated with cancer progression, pregnancy, cardiovascular diseases, central nervous system-related diseases, immune responses and viral pathogenicity. However, study on the role of exosomes in the immune response of teleost fish, especially antiviral immunity, is limited. Herein, serum-derived exosomes from mandarin fish were used to investigate the antiviral effect on the exosomes of teleost fish. Exosomes isolated from mandarin fish serum by ultra-centrifugation were internalized by mandarin fish fry cells and were able to inhibit Infectious spleen and kidney necrosis virus (ISKNV) infection. To further investigate the underlying mechanisms of exosomes in inhibiting ISKNV infection, the protein composition of serum-derived exosomes was analyzed by mass spectrometry. It was found that myxovirus resistance 1 (Mx1) was incorporated by exosomes. Furthermore, the mandarin fish Mx1 protein was proven to be transferred into the recipient cells though exosomes. Our results showed that the serum-derived exosomes from mandarin fish could inhibit ISKNV replication, which suggested an underlying mechanism of the exosome antivirus in that it incorporates Mx1 protein and delivery into recipient cells. This study provided evidence for the important antiviral role of exosomes in the immune system of teleost fish.
Asunto(s)
Infecciones por Virus ADN , Exosomas , Enfermedades de los Peces , Proteínas de Peces , Peces , Iridoviridae , Proteínas de Resistencia a Mixovirus , Animales , Línea Celular , Infecciones por Virus ADN/sangre , Infecciones por Virus ADN/inmunología , Infecciones por Virus ADN/veterinaria , Exosomas/inmunología , Exosomas/metabolismo , Enfermedades de los Peces/sangre , Enfermedades de los Peces/inmunología , Proteínas de Peces/sangre , Proteínas de Peces/inmunología , Peces/sangre , Peces/inmunología , Peces/virología , Iridoviridae/inmunología , Iridoviridae/metabolismo , Proteínas de Resistencia a Mixovirus/sangre , Proteínas de Resistencia a Mixovirus/inmunologíaRESUMEN
Torque teno virus (TTV) is a commensal human virus observed as a circular single-negative-strand DNA molecule in various tissues and biological samples, notably in blood serum and lymphocytes. TTV has no apparent clinical significance, although it might be very useful as a prospective tool for gene delivery or as an epidemiological marker. Human populations are ubiquitously infected with TTV; the prevalence may reach 100%. The majority of babies become spontaneously infected with TTV, so that by the end of the first year of life, the prevalence reaches 'adult' values. TTV positivity in healthy early infancy and the presence of TTV in umbilical cord blood samples have been reported. The mechanism of infection and the dynamics of TTV prevalence in infants with age remain understudied. Meanwhile, the potential diagnostic and prognostic value of TTV as a marker deserves special attention and study, along with the possibility, causes and consequences of placental transmission of TTV under normal or pathological conditions.
Asunto(s)
Infecciones por Virus ADN/virología , Torque teno virus/fisiología , Factores de Edad , Infecciones por Virus ADN/sangre , Infecciones por Virus ADN/genética , ADN Viral/genética , Femenino , Humanos , Lactante , Recién Nacido , Embarazo , Prevalencia , Reacción en Cadena en Tiempo Real de la Polimerasa , Carga ViralRESUMEN
INTRODUCTION: Torque teno virus (TTV) is a non-pathogenic anellovirus commonly found in the blood of human beings. Emerging data suggest that TTV viral load is proportional to the degree of immunosuppression, but its seroprevalence is unknown in Australia. We aimed to determine the seroprevalence of TTV in an Australian population of renal patients. METHODS: We developed a real-time PCR to measure TTV viral load, using the TaqMan platform and previously published primers and probes. Following ethics approval and informed consent, we collected blood from hemodialysis patients not receiving immunosuppression, and renal transplant patients. All patients were recruited from a single teaching hospital in New South Wales. RESULTS: We enrolled 50 hemodialysis and 30 renal transplant patients. 56 (70%) were males, and the mean (sd) age was 61 (16) years. TTV was detectable in plasma of 40/50 (80%) of hemodialysis patients and 28/30 (93%) of transplant patients. The mean TTV viral load was higher in transplant patients than in dialysis patients (6.3 log versus 5.0 log copies/ml, P = .001). CONCLUSIONS: Torque teno virus is prevalent in Australian renal patients and thus may be a useful novel marker to help tailor immunosuppressive therapy in renal transplant patients. Further work is needed to establish TTV seroprevalence in other regions and patient groups, and to investigate whether there is correlation with clinically important events (infection and rejection episodes) in longitudinal studies.
Asunto(s)
Infecciones por Virus ADN/epidemiología , ADN Viral/sangre , Trasplante de Riñón , Diálisis Renal , Torque teno virus/aislamiento & purificación , Anciano , Australia/epidemiología , Biomarcadores/sangre , Estudios Transversales , Infecciones por Virus ADN/sangre , Infecciones por Virus ADN/virología , Femenino , Humanos , Terapia de Inmunosupresión , Masculino , Persona de Mediana Edad , Reacción en Cadena en Tiempo Real de la Polimerasa , Estudios Seroepidemiológicos , Torque teno virus/genética , Carga ViralRESUMEN
Background: Drug-induced immunosuppression following kidney transplantation is crucial to prevent allograft rejection, but increases risk for infectious disease. Tailoring of drug dosing to prevent both rejection and infection is greatly desirable. The apathogenic and ubiquitous torque teno virus (TTV) reflects immunocompetence of the host and might be a potential candidate for immunologic monitoring. Methods: To assess TTV as an infection biomarker, virus load was prospectively quantified in peripheral blood of 169 consecutive renal allograft recipients at the Medical University Vienna. Results: Patients with infection showed higher TTV levels compared to patients without infection (4.2 × 108 copies/mL [interquartile range, IQR, 2.7 × 107-1.9 × 109] vs 2.9 × 107 [IQR 1.0 × 106-7.2 × 108]; P = .006). Differences in TTV load became evident almost 3 months before infection (median 77 days, IQR 19-98). Each log level of TTV copies/mL increased the odds ratio for infection by 23% (95% confidence interval 1.04-1.45; P = .014). TTV >3.1 × 109 copies/mL corresponded to 90% sensitivity to predict infections. Logistic regression demonstrated independent association between TTV levels and infection. Conclusions: TTV quantification predicts infection after kidney transplantation and might be a potential tool to tailor immunosuppressive drug therapy.
Asunto(s)
Infecciones por Virus ADN/sangre , Infecciones por Virus ADN/diagnóstico , Trasplante de Riñón/efectos adversos , Torque teno virus/aislamiento & purificación , Viremia/sangre , Adulto , Aloinjertos , Biomarcadores/sangre , Infecciones por Virus ADN/virología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Factores de Riesgo , Carga ViralRESUMEN
Torquetenovirus (TTV) has been proposed as a marker of immune function in patients receiving immunosuppression after solid organ transplantation. This study aimed to define TTV plasma dynamics and investigate clinical associations in patients following allogeneic hematopoietic stem cell transplantation (HSCT). This was a single-center prospective longitudinal study involving 50 consecutive patients treated with HSCT between March 2015 and April 2016. TTV plasma DNA levels were measured with quantitative PCR at 12 consecutive time points during the first year after HSCT. Forty of the 50 patients (80%) had detectable TTV viremia before HSCT (median level, 5.37 log10 copies/mL; interquartile range [IQR], 3.51-6.44 log10 copies/mL). All patients subsequently developed TTV viremia during the follow-up period. Plasma viral loads evolved dynamically over time, with a peak of 8.32 log10 copies/mL (IQR, 7.33-9.35 log10 copies/mL) occurring at 79 days (IQR, 50-117 days) following HSCT and a stable plateau toward the end of the follow-up period. The type of malignancy, the use of antithymocyte globulin during conditioning, and the occurrence of acute graft-versus-host disease requiring systemic therapy had temporary effects on TTV dynamics. TTV levels showed a significant correlation with absolute lymphocyte counts following engraftment (rs = -.27; P < .01) and with cytomegalovirus (CMV; rs=.39; P < .01) and Epstein-Barr virus (EBV; rs=.45; P = .02) viral loads during phases of viremia. Immune-related clinical events were not predicted by TTV levels. TTV viremia occurred universally and was sustained throughout the first year after HSCT. Several variables and events before and after HSCT were correlated with TTV levels and hint toward immune marker properties of TTV, but their complex interactions might perturb the capability of TTV to predict immune-related complications in this population.
Asunto(s)
Biomarcadores/análisis , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Torque teno virus/fisiología , Adulto , Biomarcadores/sangre , Citomegalovirus , Infecciones por Virus ADN/sangre , Infecciones por Virus ADN/inmunología , ADN Viral/sangre , Femenino , Herpesvirus Humano 4 , Humanos , Estudios Longitudinales , Recuento de Linfocitos , Masculino , Estudios Prospectivos , Trasplante Homólogo/efectos adversos , Carga ViralRESUMEN
BACKGROUND: Torque teno virus is a small chronically persisting circular negative ssDNA virus reaching near 100% prevalence. It is reported to be a marker for immune function in immunocompromised patients. The possibility of vertical maternal-fetal transmission remains controversial but incidence rate of TTV DNA in children increased with age. TTV dynamics well studied for allogeneic hematopoietic stem cell transplantation as a predictor of post-transplant complications but there is no viral proliferation kinetics data for other patient groups or healthy individuals. The aim of this study was to determine TTV dynamics during the first year of life of healthy infants. METHODS: Ninety eight clinically healthy breastfeeding infants (1-12 months of age) were analyzed by quantitative PCR for the whole blood TTV load with the test sensitivity of about 1000 viral copies per milliliter of blood (total number of samples including repeatedly tested infants was 109). RESULTS: 67% of all analyzed samples were TTV-positive demonstrating significant positive correlation between age and TTV load (r = 0.81, p < 0.01). CONCLUSIONS: This is the first study to suggest that viral load increases during the first year of life reaching a plateau after 6 months with strong proliferation for the first 60 days. Our data well correlates with TTV dynamics in patients following allogeneic hematopoietic stem cell transplantation.
Asunto(s)
Infecciones por Virus ADN/virología , Torque teno virus/fisiología , Factores de Edad , Infecciones por Virus ADN/sangre , Infecciones por Virus ADN/genética , ADN Viral/genética , Femenino , Humanos , Lactante , Masculino , Prevalencia , Reacción en Cadena en Tiempo Real de la Polimerasa , Sensibilidad y Especificidad , Carga ViralRESUMEN
BACKGROUND: While viral surveillance of cytomegalovirus (CMV), Epstein-Barr virus (EBV), and adenovirus using PCR is routine in patients undergoing hematopoetic stem cell transplant and solid organ transplant, the utility in the nontransplant pediatric leukemia population is unknown. Our institution screens patients with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) for viral DNAemia by PCR as part of clinical care. PROCEDURE: This retrospective chart review included patients treated for newly diagnosed or relapsed AML or ALL between April 2010 and September 2014. We retrieved data for viral PCR screening, detection and quantification, duration of positivity, and prophylaxis or treatment. RESULTS: One hundred eleven patients were included in analyses. Forty (36.0%) had at least one blood PCR positive for EBV, CMV, or adenovirus. Patients with ALL had significantly higher rates of persistent viral detection and treatment than those with AML (P < 0.02, P < 0.01, respectively). International patients had significantly higher rates of viral detection (P < 0.01), persistence (P < 0.01), any treatment (P < 0.03), and antiviral treatment (P < 0.01); 16.9% of patients who received intravenous immunoglobulin (IVIG) prophylactically had viral detection compared to 63% of patients who did not receive prophylactic IVIG (P = 0.0008). CONCLUSIONS: Patients with ALL were more susceptible than those with AML to viral reactivation that was persistent or resulted in treatment. Patients with relapsed ALL, refractory ALL, or infantile ALL are most likely to benefit from asymptomatic screening for CMV and adenovirus. International patients are at higher risk for reactivation and may merit screening. EBV reactivation was not significant and does not warrant screening.
Asunto(s)
Infecciones por Virus ADN/sangre , Virus ADN , ADN Viral/sangre , Leucemia Mieloide Aguda , Reacción en Cadena de la Polimerasa/métodos , Adolescente , Adulto , Niño , Preescolar , Infecciones por Virus ADN/prevención & control , Femenino , Humanos , Inmunoglobulinas Intravenosas/administración & dosificación , Lactante , Recién Nacido , Leucemia Mieloide Aguda/sangre , Leucemia Mieloide Aguda/virología , MasculinoRESUMEN
BACKGROUND: TTV has been detected in almost every human tissue type or body fluid reaching near 100% prevalence. Several studies report mother-to-child postnatal transmission of TTV in infancy but the risk of transplacental transmission of TTV is still unclear. METHODS: The blood and plasma collected postpartum from 100 mother-child pairs were analyzed using TTV-specific qPCR. Samples were collected from the peripheral vein of the mother and the umbilical cord. RESULTS: Eighty four percent of pregnant women were TTV positive (median titers: 8 × 104 copies/mL; range: 103 - 3 × 107). The TTV load in plasma was approximately 100 times lower than in whole blood. TTV was not detected in any of cord blood samples. CONCLUSIONS: Our data demonstrate the lack of transplacental transmission of TTV (or effective prenatal inhibition of viral proliferation). The presence of the virus in infants may be associated with mother-to-child transmission through breast feeding or other routes of transmission.
Asunto(s)
Infecciones por Virus ADN/transmisión , Transmisión Vertical de Enfermedad Infecciosa , Complicaciones Infecciosas del Embarazo/virología , Torque teno virus/aislamiento & purificación , Adulto , Infecciones por Virus ADN/sangre , Infecciones por Virus ADN/virología , ADN Viral/sangre , Femenino , Sangre Fetal/virología , Humanos , Lactante , Persona de Mediana Edad , Embarazo , Reacción en Cadena en Tiempo Real de la Polimerasa , Federación de Rusia , Torque teno virus/genética , Torque teno virus/patogenicidad , Carga ViralRESUMEN
Since the emergence of cyprinid herpesvirus 3 (CyHV-3), outbreaks have been devastating to Common Carp Cyprinus carpio and koi (a variant of Common Carp), leading to high economic losses. Current diagnostics for detecting CyHV-3 are limited in sensitivity and are further complicated by latency. Here we describe the detection of CyHV-3 by recombinase polymerase amplification (RPA). The RPA assay can detect as low as 10 copies of the CyHV-3 genome by an isothermal reaction and yields results in approximately 20 min. Using the RPA assay, the CyHV-3 genome can be detected in the total DNA of white blood cells isolated from koi latently infected with CyHV-3, while less than 10% of the latently infected koi can be detected by a real-time PCR assay in the total DNA of white blood cells. In addition, RPA products can be detected in a lateral flow device that is cheap and fast and can be used outside of the diagnostic lab. The RPA assay and lateral flow device provide for the rapid, sensitive, and specific amplification of CyHV-3 that with future modifications for field use and validation could lead to enhanced surveillance and early diagnosis of CyHV-3 in the laboratory and field. Received September 14, 2015; accepted April 9, 2016.
Asunto(s)
Carpas , Infecciones por Virus ADN/veterinaria , Virus ADN/aislamiento & purificación , Enfermedades de los Peces/sangre , Enfermedades de los Peces/patología , Técnicas de Amplificación de Ácido Nucleico/veterinaria , Animales , Infecciones por Virus ADN/sangre , Infecciones por Virus ADN/patología , Infecciones por Virus ADN/virología , Enfermedades de los Peces/virología , Reacción en Cadena en Tiempo Real de la Polimerasa/veterinaria , Recombinasas/análisisRESUMEN
Outbreaks of cyprinid herpesvirus 2 (CyHV-2) disease, also known as herpesviral hematopoietic necrosis, among cultured Prussian Carp Carassius gibelio has occurred each year in Jiangsu province, China, since 2009. In autumn 2014, hematological, blood biochemical, and histological changes in naturally infected moribund Prussian Carp were investigated after CyHV-2 was confirmed as the sole etiologic agent by etiological analyses. Total erythrocyte count, total leukocyte count, hemoglobin concentration, and thrombocyte count were significantly reduced (P < 0.01), whereas erythrocyte osmotic brittleness was significantly increased (P < 0.01) in infected fish compared with control fish. In addition, monocyte count was higher (P < 0.01) and lymphocyte count was lower (P < 0.01) in diseased fish than in control fish. The blood biochemical analyses indicated significant increases (P < 0.01) in the activities of alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, and lactate dehydrogenase as well as in the levels of total protein, globulin, total bilirubin, creatinine, and urea along with significant decreases (P < 0.01) in glucose and albumin in the diseased group. Histopathological examinations indicated that the kidneys and spleens of moribund Prussian Carp were the most severely lesioned organs, followed by the gills and hearts. Hypertrophied nuclei with marginated chromatin also appeared in the hearts and renal tubular epithelia from diseased fish. Pathological analysis of blood cells showed that approximately 78% of erythrocytes and 94% of leukocytes were lesioned with different levels of degeneration and necrosis in the diseased group. These previously unreported observations may be useful in the diagnosis of CyHV-2 disease. Received May 11, 2015; accepted March 24, 2016.
Asunto(s)
Carpas , Infecciones por Virus ADN/veterinaria , Virus ADN/aislamiento & purificación , Enfermedades de los Peces/sangre , Enfermedades de los Peces/patología , Animales , China , Infecciones por Virus ADN/sangre , Infecciones por Virus ADN/patología , Infecciones por Virus ADN/virología , Enfermedades de los Peces/virología , Reacción en Cadena de la Polimerasa/veterinariaRESUMEN
BACKGROUND: A new Marseilleviridae virus family member, giant blood Marseille-like (GBM) virus, was recently reported in persons from France in the serum of an infant with adenitis, in the blood of 4% of healthy blood donors, and in 9% of multiply transfused thalassemia patients. These results suggested the presence of a nucleocytoplasmic large DNA virus potentially transmissible by blood product transfusion. STUDY DESIGN AND METHODS: To investigate this possibility we tested the plasma from 113 US blood donors and 74 multiply transfused Cameroon patients for GBM viral DNA using highly sensitive polymerase chain reaction (PCR) assays. RESULTS: GBM DNA was not detected by nested PCR in any of these 187 human specimens. CONCLUSIONS: Further testing is required to confirm the occurrence of human GBM virus infections.
Asunto(s)
Donantes de Sangre , Infecciones por Virus ADN/virología , Virus ADN/aislamiento & purificación , ADN Viral/sangre , Reacción en Cadena de la Polimerasa/métodos , Viremia/virología , Acanthamoeba/virología , Adulto , Anticuerpos Antivirales/sangre , Camerún/epidemiología , Cartilla de ADN , Infecciones por Virus ADN/sangre , Infecciones por Virus ADN/epidemiología , Infecciones por Virus ADN/transmisión , Virus ADN/genética , Virus ADN/inmunología , Francia/epidemiología , Humanos , Células Jurkat/virología , Masculino , Persona de Mediana Edad , Sistemas de Lectura Abierta/genética , Plasma/virología , Sensibilidad y Especificidad , Suero/virología , Reacción a la Transfusión , Estados Unidos/epidemiología , Proteínas Virales/sangre , Proteínas Virales/genética , Viremia/sangre , Viremia/epidemiología , Cultivo de VirusRESUMEN
AIM: Viruses from genus Anelloviridae (TTV, TTMDV and TTMV) are small DNA viruses that are widespread in human popu- lation. Data on tissue tropism, cell localization and morphometry of anelloviruses are scarce. The purpose of this study was to determine the prevalence of TTV, TTMDV and TTMV in persons with liver disease and in healthy individuals, as well as electron-microscopic verification of Anelloviridae species. METHODS: Detection of anelloviral DNA was performed in serum samples from 203 patients with liver diseases of various etiology and 115 voluntary blood donors using PCR with primers allowing to differentiate TTV, TTMDV TTMV based on the length of amplified fragment. Histopathological and electron microscopic studies were performed for liver biopsy specimens from 203 patients with liver disease. RESULTS: High prevalence (70-90%) of all three anelloviruses in healthy individuals and patients with liver disease was demonstrated, with high frequency of triple TTV, TTMDV and TTMV infection (52.2-55.7%). Electron-microscopic study of liver biopsy specimens from TTMDV monoinfected patients gave a submicroscopic image of TTMDV virions with diameter 35.86 ± 2.04 nm. Electron microscopic studies confirmed the nature of liver damage in TTMDV monoinfection: accumulation of virus in the hepatocytes, significant cyropathy with enlightenment matrix of the cytoplasm and reduction of intracellula organelles involved in protein synthesis, portal and perivascular perisinusoidal fibrosis. TTV, TTMDV and TTMV virions were dentified in hepatocytes, confirming these viruses to be hepatotropic. CONCLUSION: Our results demonstrate that anelloviruses are lymphotropic viruses, individual genotypes of those might be hepatotropic and pathogenic to liver.
Asunto(s)
Anelloviridae , Donantes de Sangre , Infecciones por Virus ADN , Hepatopatías , Hígado , Anelloviridae/clasificación , Anelloviridae/genética , Enfermedad Crónica , Infecciones por Virus ADN/sangre , Infecciones por Virus ADN/genética , Infecciones por Virus ADN/patología , Infecciones por Virus ADN/virología , Femenino , Humanos , Hígado/ultraestructura , Hígado/virología , Hepatopatías/sangre , Hepatopatías/genética , Hepatopatías/patología , Hepatopatías/virología , MasculinoRESUMEN
Ranavirus is an emerging disease that infects fish, amphibians, and reptiles. Ranavirus induces an inflammatory response leading to death in many susceptible species. Red-eared sliders (RES; Trachemys scripta elegans) are vulnerable to ranavirus infection and are economically significant chelonians kept in the pet trade and utilized in research. Early identification of RES with inflammatory diseases would allow for isolation of affected individuals and subsequent disease investigation, including molecular testing for ranavirus. Validation of an inexpensive, clinically relevant, and reproducible diagnostic test that detects inflammation in turtles is needed. Although commonly used, plasma protein electrophoresis to detect an inflammatory acute-phase protein response has not been evaluated in a controlled environment in turtles with experimentally induced inflammatory disease. The objective of this study was to measure plasma protein fractions by electrophoresis to determine if an acute-phase protein response occurs in RES during infection with a frog virus 3-like ranavirus (FV3-like virus) isolated from a chelonian. A Bradford assay and agarose gel electrophoresis (AGE) were performed using plasma collected during a study of the effect of temperature on the pathogenesis of ranavirus in RES. In RES at the time of viremia, total albumin (ALB(mg/ml)) and albumin to globulin ratio were significantly lower and beta-globulin percentage was significantly higher in RES exposed to ranavirus (n = 4) as compared to matched, uninfected RES (n = 8). In the last sample collected prior to death, total protein (TP(mg/ml)), ALB(mg/ml), alpha-globulin percentage, and total alpha-globulin (alpha(mg/ml)) were significantly lower in RES exposed to ranavirus (n = 4) than control individuals (n = 8). In summary, FV3-like virus induces a decrease in plasma albumin concentration at the onset ofviremia and decreases in TP(mg/ml, ALB(mg/ml), and alpha(mg/ml) concentrations prior to death in RES as measured by AGE.
Asunto(s)
Proteínas Sanguíneas/metabolismo , Infecciones por Virus ADN/veterinaria , Ranavirus , Tortugas/sangre , Animales , Infecciones por Virus ADN/sangre , Infecciones por Virus ADN/virología , ViremiaRESUMEN
Ranaviruses are pathogens of ectothermic vertebrates (fish, amphibians, and reptiles). Turtles are the most common group of reptiles reported with ranaviral infections. However, there have been no surveys for wild ranaviral infection in any turtles from the suborder Pleurodira, despite ranaviral distributions and experimentally susceptible pleurodiran turtle populations overlapping in several areas, including Australia. We assayed 397 pooled blood samples from six Australian freshwater turtle species collected from five different sites in northern Australia between 2014 and 2019. Historical serologic surveys in the area had found antiranaviral antibodies; however, we did not detect any ranaviral DNA in our samples. Discrepancies between historical serologic and our molecular results may be explained by low viral prevalence during the years that these samples were collected, survivorship bias, or possibly an age class bias in sampling.
Asunto(s)
Infecciones por Virus ADN , Ranavirus , Tortugas , Animales , Tortugas/virología , Tortugas/sangre , Infecciones por Virus ADN/veterinaria , Infecciones por Virus ADN/epidemiología , Infecciones por Virus ADN/virología , Infecciones por Virus ADN/sangre , Australia/epidemiología , ADN Viral/sangreRESUMEN
BACKGROUND: Long-term allograft and patient survival after kidney transplantation (KTX) depends on the balance between over- and under-immunosuppression (IS). High levels of IS predispose to opportunistic infections. Plasma load of Torque Teno Virus (TTV), a non-pathogenic highly prevalent Annellovirus, is associated with its hosts immune status, especially after solid organ transplantation. OBJECTIVES: To investigate the association of plasma TTV load and opportunistic viral infections after pediatric KTX. STUDY DESIGN: This retrospective study includes all pediatric KTX patients followed at the Medical University of Vienna 2014-2020. PCR for Cytomegalovirus (CMV), Epstein-Barr virus (EBV), BK virus (BKV), and TTV was performed every 4-8 weeks at routine follow-up visits. RESULTS: 71 pediatric KTX patients were followed with TTV measurements for a median of 2.7 years. TTV plasma load was associated with CMV DNAemia at the next visit with an OR of 2.37 (95 % CI 1.15-4.87; p = 0.03) after adjustment for time after KTX and recipient age. For a cut-off of 7.68 log10 c/mL TTV a sensitivity of 100 %, a specificity of 61 %, a NPV 100 %, and a PPV of 46 % to detect CMV DNAemia at the next visit was calculated. TTV plasma loads were also associated with BKV DNAuria and BKV DNAemia at the next visit, but not with EBV DNAemia. CONCLUSIONS: This is the first study to analyse associations between TTV plasma loads and opportunistic viral infections in pediatric KTX. We were able to present a TTV cut-off for the prediction of clinically relevant CMV DNAemia that might be useful in clinical care.